GIP (22-51) human, CAS [[957470-49-4]] Preis auf Anfrage

Produktübersicht

• Artikelname: GIP (22-51) human, CAS [[957470-49-4]] Preis auf Anfrage
• Artikelnummer: TGM-TP3711
• Hersteller Artikelnummer: TP3711
• Alternativnummer: TGM-TP3711-10MG,TGM-TP3711-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: Glucose-dependent Insulinotropic Peptide (22-51) (human)

Produktbeschreibung

GIP (22-51) human (Glucose-dependent Insulinotropic Peptide (22-51) human) is a potent pro-atherosclerotic peptide hormone composed of 30 amino acids. It activates the NF-kappaB signaling pathway, enhances the expression of MMP-8, and induces the expression of pro-inflammatory and pro-atherogenic proteins. Additionally, it increases intracellular free Ca2+ levels in THP-1 induced macrophages. GIP (22-51) human is useful for atherosclerosis research.

Produkteigenschaften

• Molekulargewicht: 3181.56
• CAS Nummer: [957470-49-4]
• Formel: C140H226N44O41
• Target-Kategorie: MMP|||NF-kappaB|||Calcium Channel

Bilder

TP3711